Cutler Group LP Geron Corp Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Geron Corp stock. As of the latest transaction made, Cutler Group LP holds 600 shares of GERN stock, worth $2,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600
Previous 800
25.0%
Holding current value
$2,130
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GERN
# of Institutions
247Shares Held
374MCall Options Held
1.48MPut Options Held
1.18M-
Black Rock Inc. New York, NY41.4MShares$147 Million0.0% of portfolio
-
State Street Corp Boston, MA31.6MShares$112 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT30.5MShares$108 Million3.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.9MShares$106 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$96.6 Million12.02% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.34B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...